Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

Also called NCT01626534

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 125 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01626534
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01626534. Randomized; no masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2014-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel
Intervention (Drug)
trigagrelor
Lead sponsor
Assistance Publique Hopitaux De Marseille (class: other)

Record details

Record id
cardio:ct-nct01626534
Content hash
1abf4d0705f52442a3f9e6711d3d101f25ae0dee816d8accaaa027115f946b8c